Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA: Bernard Courtieu, Jean-Pol Detiffe, Eduardo Bravo

OncoDNA has appointed Bernard Courtieu as CEO and Jean-Pol Detiffe as chief strategic and innovation officer. Courtieu previously served as CEO of IntegraGen, which was acquired by OncoDNA last July. Prior to IntegraGen, Courtieu served as VP at Gemini Consulting.

Eduardo Bravo, who currently serves as interim CEO of OncoDNA, will remain a consultant to the firm's board. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.